Application of adipose tissue-derived stem cell therapy with a clinically relevant dose does not significantly affect atherosclerotic plaque characteristics in a streptozotocin-induced hyperglycaemia mouse model.

3 F) in the ASC group were lower than in the vehicle group (CD45: 8.3±5.2%; mast cells: 5.4±2.7%), this did not reach statistical significance ( p =0.2). 3.3.

also in 111,027 other papers

Despite a borderline significant improvement in intraplaque fibrotic content, the potential of ASC treatment on atherosclerotic plaque stability in a diabetic environment remains to be determined.

also in 11,409 other papers